Find the latest Innate Pharma SA (IPHP.XD) stock quote, history, news and other vital information to help you with your stock trading and investing.
As of April 16 at 12:53:17 PM GMT+1. Market Open.
Earnings call Innate Pharma reported Q3 2025 with a cash position of EUR 56.4 million, providing runway through Q3 2026. The quarter was defined by FDA clearance to initiate the phase III TELLOMAK 3 ...
At close: 16 April at 12:53:17 pm GMT+1 ...
As of 1:29:13 pm GMT+1. Market open.
At close: 22 June at 5:29:30 pm GMT+2 ...
At close: 17 April at 17:26:17 CEST ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results